Dexsotalol hydrochloride

Drug Profile

Dexsotalol hydrochloride

Alternative Names: BMY 057631D; d-Sotalol

Latest Information Update: 16 Sep 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Class III antiarrhythmics; Small molecules
  • Mechanism of Action Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 16 Sep 1996 A study has been added to the Arrhythmias pharmacodynamics section
  • 13 Sep 1996 d-Sotalol is now called dexsotalol hydrochloride
  • 12 Sep 1996 A study has been added to the Arrhythmia therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top